BackConcert Pharmaceuticals Overview

Concert Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for CNCE.

Quarterly EBIT

-$29.61M
↓ 10.98% YoY

As of Sep 30, 2022

Annual EBIT (TTM)

-$68.73M
↓ 3.64% YoY

Trailing 12 months ending Sep 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin